Contineum Therapeutics, Inc. Class A Balance Sheet
Contineum Therapeutics, Inc. Class A's total assets for Q3 2024 were $216.03M, a decrease of -2.40% from the previous quarter. CTNM total liabilities were $5.81M for the fiscal quarter, a 50.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23
Dec 22
Dec 21
Total Assets
$ 130.39M
$ 50.64M
$ 70.52M
Total Liabilities
$ 198.32M
$ 143.85M
$ 141.41M
Total Equity Gross Minority
$ -67.94M
$ -93.21M
$ -70.89M
Other Metrics
$ ―
$ ―
$ ―
Currency in USD
Contineum Therapeutics, Inc. Class A Debt to Assets